Siplizumab selectively depletes effector memory T-cells and promotes a relative expansion of alloreactive regulatory T-cells in vitro

Siplizumab, a humanized anti-CD2 monoclonal antibody, has been used in conditioning regimens for hematopoietic cell transplantation and tolerance induction with combined kidney-bone marrow transplantation. Siplizumab-based tolerance induction regimens deplete T cells globally while enriching regulat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Transplant
Prif Awduron: Podestà, Manuel Alfredo, Binder, Christian, Sellberg, Felix, DeWolf, Susan, Shonts, Brittany, Ho, Siu-Hong, Obradovic, Aleksandar, Waffarn, Elizabeth, Danzl, Nichole, Berglund, David, Sykes, Megan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940533/
https://ncbi.nlm.nih.gov/pubmed/31319439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15533
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg